BridgeMD
New treatment option for Malnutrition
Official title Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)
ClinicalTrials.gov ID: NCT07072377
What this study is testing
- What it's testing
- Brief Summary The goal of this clinical trial is to evaluate the acceptability and adherence of low- and high-intensity remote nutritional interventions for cancer patients in rural and urban areas, specifically focusing on those with invasive cancer who are about to start treatment. The main question(s) it aims to answer are: Can low- and high-intensity remote nutritional interventions improve adherence to cancer treatment and quality of life?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of invasive cancer with plans to initiate chemo-, immune-, targeted-, or hormonal therapy for treatment of their malignancy, or within one...
- Age ≥ 18 years of age.
- Patients must be able to read, write, and speak English as study material and virtual nutrition consultation calls are only available in English.
- Patients receiving treatment at a participating ambulatory medical oncology site.
- Willingness to have a remote nutritional consultation and complete questionnaires/surveys.
You likely can't join if
- Diagnosis of acute leukemia (these patients generally receive predominantly inpatient care).
- Diagnosis of head \& neck cancer, esophageal cancer, gastric cancer, patients presenting with recognized cachexia or severe malnutrition, or patients...
See the full eligibility criteria
- Diagnosis of invasive cancer with plans to initiate chemo-, immune-, targeted-, or hormonal therapy for treatment of their malignancy, or within one month of starting treatment.
- Age ≥ 18 years of age.
- Patients must be able to read, write, and speak English as study material and virtual nutrition consultation calls are only available in English.
- Patients receiving treatment at a participating ambulatory medical oncology site.
- Willingness to have a remote nutritional consultation and complete questionnaires/surveys.
- Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.
- Diagnosis of acute leukemia (these patients generally receive predominantly inpatient care).
- Diagnosis of head \& neck cancer, esophageal cancer, gastric cancer, patients presenting with recognized cachexia or severe malnutrition, or patients with PEG tubes for enteral feeding. Rationale: These patients would...
The study team makes the final eligibility decision.
Where it's taking place
- Burlington, Vermont, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Burlington, Vermont, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.